What type of cancer is Tecentriq used to treat?
Medically reviewed by Drugs.com Last updated on Dec 5, 2019.
Official Answerby Drugs.com
Tecentriq (atezolizumab) is used to treat:
- urothelial cancer
- non-small cell lung cancer (NSCLC)
- small cell lung cancer (SCLC)
- triple-negative breast cancer (TNBC)
Tecentriq was the first programmed death-ligand 1 (PD-L1) blocking antibody approved by the FDA.
Tecentriq belongs to a class of immunotherapy drugs called immune checkpoint inhibitors and works by boosting the body’s immune system to help it attack cancer cells. Immune checkpoint inhibitors may also allow the immune system to attack normal organs in the body which may lead to serious side effects, but overall these drugs are better tolerated than many of the older standard cancer treatments.
Common side effects with Tecentriq may include fatigue, loss of appetite, and nausea. Other more serious side effects may include hepatitis, inflammation in the lungs, intestines, or other organs.
Related Medical Questions
- What is the cost of Tecentriq?
- How do you take Kisqali?
- How do you take Nerlynx?
- What type of drug is Verzenio?
- What is the difference between Ogivri and Herceptin?
- What type of drug is Talzenna?
- What is the difference between Herzuma and Herceptin?